| Date | Form | Description | Docs | XBRL | Pages |
| 09/27/18 | 8-K | Current report filing |
|
12 | |
| 09/19/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/18/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/17/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/14/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/13/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/07/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
33 |
| 08/17/18 | DEF 14A | Definitive proxy statements |
|
51 | |
| 07/27/18 | 8-K | Current report filing |
|
3 |
Latest News & Events
Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
Read More...Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
Read More...Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office
Read More...